Research on seasonal influenza vaccines has shown that a quadrivalent mRNA vaccine can prevent and mitigate influenza infection. Studies have investigated the immunogenicity and safety of mRNA-based seasonal influenza vaccines, with some focusing on specific aspects such as vaccine strain selection and adjuvants. The effectiveness of these vaccines in various contexts, including their ability to protect against different strains of the influenza virus, is being explored in ongoing research.